• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童癌症幸存者炎症衰老的生物学方面

Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors.

作者信息

Rossi Francesca, Di Paola Alessandra, Pota Elvira, Argenziano Maura, Di Pinto Daniela, Marrapodi Maria Maddalena, Di Leva Caterina, Di Martino Martina, Tortora Chiara

机构信息

Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138 Napoli, Italy.

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via S. Maria di Costantinopoli 16, 80138 Napoli, Italy.

出版信息

Cancers (Basel). 2021 Sep 30;13(19):4933. doi: 10.3390/cancers13194933.

DOI:10.3390/cancers13194933
PMID:34638416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8508005/
Abstract

Anti-cancer treatments improve survival in children with cancer. A total of 80% of children treated for childhood cancer achieve 5-year survival, becoming long-term survivors. However, they undergo several chronic late effects related to treatments. In childhood cancer survivors a chronic low-grade inflammation, known as inflamm-aging, is responsible for frailty, a condition characterized by vital organ failure and by premature aging processes. Inflamm-aging is closely related to chemotherapy and radiotherapy, which induce inflammation, accumulation of senescent cells, DNA mutations, and the production of reactive oxygen species. All these conditions are responsible for the onset of secondary diseases, such as osteoporosis, cardiovascular diseases, obesity, and infertility. Considering that the pathobiology of frailty among childhood cancer survivors is still unknown, investigations are needed to better understand frailty's biological and molecular processes and to identify inflamm-aging key biomarkers in order to facilitate the screening of comorbidities and to clarify whether treatments, normally used to modulate inflamm-aging, may be beneficial. This review offers an overview of the possible biological mechanisms involved in the development of inflamm-aging, focusing our attention on immune system alteration, oxidative stress, cellular senescence, and therapeutic strategies.

摘要

抗癌治疗可提高儿童癌症患者的生存率。接受儿童癌症治疗的儿童中,共有80%实现了5年生存,成为长期幸存者。然而,他们会经历与治疗相关的几种慢性晚期效应。在儿童癌症幸存者中,一种称为炎症衰老的慢性低度炎症是导致虚弱的原因,虚弱是一种以重要器官功能衰竭和过早衰老过程为特征的状况。炎症衰老与化疗和放疗密切相关,化疗和放疗会引发炎症、衰老细胞的积累、DNA突变以及活性氧的产生。所有这些情况都会导致继发性疾病的发生,如骨质疏松症、心血管疾病、肥胖症和不孕症。鉴于儿童癌症幸存者中虚弱的病理生物学仍然未知,需要进行研究以更好地了解虚弱的生物学和分子过程,并确定炎症衰老的关键生物标志物,以便于筛查合并症,并阐明通常用于调节炎症衰老的治疗方法是否有益。本综述概述了炎症衰老发展过程中可能涉及的生物学机制,重点关注免疫系统改变、氧化应激、细胞衰老和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/fae16d1d1b27/cancers-13-04933-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/fbf673fc3052/cancers-13-04933-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/20b22aab0e31/cancers-13-04933-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/2e2e09365036/cancers-13-04933-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/fae16d1d1b27/cancers-13-04933-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/fbf673fc3052/cancers-13-04933-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/20b22aab0e31/cancers-13-04933-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/2e2e09365036/cancers-13-04933-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c92/8508005/fae16d1d1b27/cancers-13-04933-g004.jpg

相似文献

1
Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors.儿童癌症幸存者炎症衰老的生物学方面
Cancers (Basel). 2021 Sep 30;13(19):4933. doi: 10.3390/cancers13194933.
2
Exploring the emerging bidirectional association between inflamm-aging and cellular senescence in organismal aging and disease.探索炎症性衰老与细胞衰老在机体衰老和疾病中的新兴双向关联。
Cell Biochem Funct. 2024 Mar;42(2):e3970. doi: 10.1002/cbf.3970.
3
Role of Nutraceuticals in Counteracting Inflammation in In Vitro Macrophages Obtained from Childhood Cancer Survivors.营养保健品在抵抗儿童癌症幸存者体外巨噬细胞炎症中的作用
Cancers (Basel). 2024 Feb 8;16(4):714. doi: 10.3390/cancers16040714.
4
MicroRNAs linking inflamm-aging, cellular senescence and cancer.微小 RNA 连接炎症性衰老、细胞衰老和癌症。
Ageing Res Rev. 2013 Sep;12(4):1056-68. doi: 10.1016/j.arr.2013.05.001. Epub 2013 May 17.
5
Premature aging in childhood cancer survivors.儿童癌症幸存者的早衰。
Oncol Lett. 2022 Dec 13;25(2):43. doi: 10.3892/ol.2022.13629. eCollection 2023 Feb.
6
Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life.儿童急性淋巴细胞白血病无症状幸存者在生命早期表现出炎症衰老的生物学特征。
Cancers (Basel). 2022 May 20;14(10):2522. doi: 10.3390/cancers14102522.
7
MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.人类炎症衰老中的微小RNA:一种涉及miR-181a、miR-34a和miR-146a的假说。
Exp Gerontol. 2014 Aug;56:154-63. doi: 10.1016/j.exger.2014.03.002. Epub 2014 Mar 7.
8
Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions.癌症幸存者的加速衰老:细胞衰老、脆弱和可能的干预机会。
Int J Mol Sci. 2024 Mar 14;25(6):3319. doi: 10.3390/ijms25063319.
9
Chronic Inflammation: Accelerator of Biological Aging.慢性炎症:生物衰老的加速器。
J Gerontol A Biol Sci Med Sci. 2017 Sep 1;72(9):1218-1225. doi: 10.1093/gerona/glw240.
10
The anti-inflamm-aging and hepatoprotective effects of huperzine A in D-galactose-treated rats.石杉碱甲对 D-半乳糖处理大鼠的抗炎抗衰老和保肝作用。
Mech Ageing Dev. 2013 Mar;134(3-4):89-97. doi: 10.1016/j.mad.2012.12.005. Epub 2013 Jan 8.

引用本文的文献

1
Biomarker-based profiling of fatigue in childhood cancer survivors: evidence for distinct inflammatory and glial-associated profiles.基于生物标志物的儿童癌症幸存者疲劳分析:不同炎症和胶质细胞相关特征的证据
Brain Behav Immun Health. 2025 Aug 11;48:101089. doi: 10.1016/j.bbih.2025.101089. eCollection 2025 Oct.
2
Correlation of FSTL1 and its paralogs with body composition in adult survivors of childhood cancer.FSTL1及其旁系同源物与儿童癌症成年幸存者身体组成的相关性。
Sci Rep. 2025 May 30;15(1):19005. doi: 10.1038/s41598-025-03013-8.
3
Bioelectrical Impedance Analysis of Body Composition in Male Childhood Brain Tumor Survivors.

本文引用的文献

1
A Systematic Review of the Safety, Feasibility and Benefits of Exercise for Patients with Advanced Cancer.晚期癌症患者运动安全性、可行性及益处的系统评价
Cancers (Basel). 2021 Sep 6;13(17):4478. doi: 10.3390/cancers13174478.
2
Life after Cell Death-Survival and Survivorship Following Chemotherapy.细胞死亡后的生命——化疗后的生存与存活情况
Cancers (Basel). 2021 Jun 11;13(12):2942. doi: 10.3390/cancers13122942.
3
Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia.m6A修饰因子和微小RNA在控制急性髓系白血病中的免疫治疗潜力
男性儿童脑肿瘤幸存者身体成分的生物电阻抗分析
Diseases. 2024 Nov 28;12(12):306. doi: 10.3390/diseases12120306.
4
Curcumin and Methotrexate: A Promising Combination for Osteosarcoma Treatment via Hedgehog Pathway Inhibition.姜黄素和甲氨蝶呤:通过 Hedgehog 通路抑制治疗骨肉瘤的有前途的联合用药。
Int J Mol Sci. 2024 Oct 21;25(20):11300. doi: 10.3390/ijms252011300.
5
Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study.鞘内化疗药物累积剂量可预测急性淋巴细胞白血病长期存活者的白质完整性:一项PETALE研究
Cancers (Basel). 2024 Mar 19;16(6):1208. doi: 10.3390/cancers16061208.
6
Role of Nutraceuticals in Counteracting Inflammation in In Vitro Macrophages Obtained from Childhood Cancer Survivors.营养保健品在抵抗儿童癌症幸存者体外巨噬细胞炎症中的作用
Cancers (Basel). 2024 Feb 8;16(4):714. doi: 10.3390/cancers16040714.
7
Evaluation of Metabolic and Cardiovascular Risk Measured by Laboratory Biomarkers and Cardiopulmonary Exercise Test in Children and Adolescents Recovered from Brain Tumors: The CARMEP Study.通过实验室生物标志物和心肺运动试验评估脑肿瘤康复儿童和青少年的代谢及心血管风险:CARMEP研究
Cancers (Basel). 2024 Jan 11;16(2):324. doi: 10.3390/cancers16020324.
8
AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers.晚期糖基化终末产物与晚期糖基化终末产物受体:恶性或转移性癌症中糖基化-炎症轴的代谢和分子特征
Explor Target Antitumor Ther. 2023;4(5):812-849. doi: 10.37349/etat.2023.00170. Epub 2023 Sep 28.
9
Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions.儿童癌症幸存者中的糖尿病:病理生理学的新观念与未来方向
Front Med (Lausanne). 2023 Aug 22;10:1206071. doi: 10.3389/fmed.2023.1206071. eCollection 2023.
10
Childhood Cancer Survivors: An Overview of the Management of Late Effects.儿童癌症幸存者:晚期效应管理概述
Cancers (Basel). 2023 Jun 11;15(12):3150. doi: 10.3390/cancers15123150.
Biomedicines. 2021 Jun 18;9(6):690. doi: 10.3390/biomedicines9060690.
4
Metabolic Syndrome in Male Survivors of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Total Body Irradiation, Low-Grade Inflammation, and Hypogonadism.儿童异基因造血干细胞移植后男性幸存者的代谢综合征:全身照射、低度炎症和性腺功能减退的影响。
Transplant Cell Ther. 2021 Sep;27(9):778.e1-778.e8. doi: 10.1016/j.jtct.2021.05.025. Epub 2021 Jun 29.
5
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.儿童癌症:发病情况、治疗及二次原发性恶性肿瘤风险
Cancers (Basel). 2021 May 26;13(11):2607. doi: 10.3390/cancers13112607.
6
Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?儿童和青少年癌症幸存者中的低度慢性炎症和免疫改变:加速衰老的一个贡献?
Cancer Med. 2021 Mar;10(5):1772-1782. doi: 10.1002/cam4.3788. Epub 2021 Feb 19.
7
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.CD38:炎症和自身免疫中的免疫调节分子。
Front Immunol. 2020 Nov 30;11:597959. doi: 10.3389/fimmu.2020.597959. eCollection 2020.
8
The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress.儿童癌症幸存者的未来:持续进步的挑战与机遇。
Pediatr Clin North Am. 2020 Dec;67(6):1237-1251. doi: 10.1016/j.pcl.2020.07.013.
9
Inflammaging, hormesis and the rationale for anti-aging strategies.慢性炎症、应激与抗衰老策略的原理。
Ageing Res Rev. 2020 Dec;64:101142. doi: 10.1016/j.arr.2020.101142. Epub 2020 Aug 16.
10
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword.NLRP3 炎性小体在癌症中的激活:一把双刃剑。
Front Immunol. 2020 Jul 8;11:1444. doi: 10.3389/fimmu.2020.01444. eCollection 2020.